Herbicides & PGRs
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Syngenta has launched the herbicide, Callisto (mesotrione 480 g/litre), in Australia.
ChemChina subsidiary Adama has received US approval for the rice herbicides, Vopak 3ME (clomazone) and Zurax L (quinclorac-methyl).
Bayer and BASF have been ordered by a US federal jury to pay damages of $265 million to a Missouri peach farmer who alleged that his crops were ruined by drift from the companies’ dicamba herbicides.
Bayer's Crop Science division highlights a new herbicide active ingredient in the latest update of its agrochemical, trait and digital farming pipeline.
Bayer has filed an application with a US state of California appeals court to overturn an $86 million verdict that found it was responsible for a couple’s cancer caused by its glyphosate-based herbicide, Roundup.
Active ingredients banned or restricted in various parts of the world in 2019/20, with links to original articles.
The US EPA has approved Bayer's Crop Science Division's herbicide, Invora (aminocyclopyrachlor + triclopyr).
Chinese companies’ production capacity for the herbicide, glyphosate, was around 725,000 tonnes in 2018, down from the high of some 940,000 tonnes in 2014.
The Canadian Pest Management Regulatory Agency (PMRA) has confirmed the continued registration of the plant growth regulator, uniconazole-P.
The Canadian Pest Management Regulatory Agency (PMRA) has approved FMC’s herbicide, Pethoxamid 480 EC (pethoxamid 480 g/litre), for use on maize and soybeans.
Bayer's Crop Science division has launched its herbicide, Luxxur (thiencarbazone-methyl + tribenuron-methyl), in the US.
South Africa has registered Syngenta's plant growth regulator, Moddus (trinexapac-ethyl 250 g/litre).
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.